About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Avastin , the Cancer Drug Brings Hope as a Cost-effective Treatment for AMD

by Savitha C Muppala on April 30, 2011 at 2:17 AM
Font : A-A+

 Avastin , the Cancer Drug Brings Hope as a Cost-effective Treatment for AMD

A recent study compared the performance of Avastin, a cancer treatment drug and Ludentis, a drug used to treat a degenerative eye disease, which showed that both drugs performed with the same level of efficiency in treating age-related macular degeneration.  

Patients who received monthly doses of Avastin were benefitted by a 8.0 letters of visual acuity as compared to an 8.5 letter improvement produced by the drug Ludentis.

Advertisement

Both drugs are manufactured by the same company, Genentech, but are differently priced.

While a single dose of Avastin costs about $50, patients will have to cough up so much more for a single dose of Ludentis, priced at about $2,000.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
Test Your Knowledge on Lung Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Cancer and Homeopathy Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Oncology Drug Delivery Systems Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Immune Checkpoint Inhibitors for Cancer Treatment 

Most Popular on Medindia

Sanatogen Daily Calorie Requirements Noscaphene (Noscapine) Loram (2 mg) (Lorazepam) Indian Medical Journals Post-Nasal Drip Diaphragmatic Hernia Calculate Ideal Weight for Infants Blood - Sugar Chart Drug - Food Interactions
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use